In fact, HMGB1 stimulates the secretion of TNF-α from macrophages and activates protumoral factors such as NF-κB, leading to chronic inflammation, autophagy and mesothelial cell transformation [65]; thus, targeting HMGB1 may be an additional potential therapy for mesothelioma. Here, TNF is linked to mesothelioma.